Vabomere

Active Ingredient(s): Meropenem + Vaborbactam
FDA Approved: * August 29, 2017
Pharm Company: * REMPEX PHARMS MEDCNS
Category: Antibiotics

Vaborbactam (INN)[1] is a non-β-lactam β-lactamase inhibitor discovered by Rempex Pharmaceuticals, a subsidiary of The Medicines Company. While not effective as an antibiotic by itself, it restores potency to existing antibiotics by inhibiting the β-lactamase enzymes that would otherwise degrade them. When combined with an appropriate antibiotic it can be used for the treatment of gram-negative bacterial infections.[2] In the United States, the c... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Vabomere Intravenous Injection, Powder, for Solution
NDC: 65293-009
Labeler:
The Medicines Company
Vabomere Intravenous Injection, Powder, for Solution
NDC: 70842-120
Labeler:
Melinta Therapeutics, Inc.